Found 107 matching trials
A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer PHASE3 This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Show More Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Learn More & Join Trial
Abraxane and RT for Non-Small Cell Lung Cancer (NSCLC) PHASE2 For patients with stage III Lung Cancer, We propose one cycle chemotherapy ...
Show More Location
University of Rochester, Medical Center
Learn More & Join Trial
Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Fox Chase Cancer Center - Philadelphia
Learn More & Join Trial
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) PHASE3 Researchers are looking for new ways to treat types of breast cancer that a...
Show More Location
Banner MD Anderson Cancer Center ( Site 0066)
Learn More & Join Trial
Adjuvant CCRT vs CT in Minimal N2 NSCLC PHASE2 This study propose adjuvant concurrent chemoradiotherapy vs chemotherapy al...
Show More Location
Samsung Medical Center
Learn More & Join Trial
Camrelizumab Combination With SBRT and Concurrent Chemotherapy Treated Stage IV Oligometastatic Non-small Cell Lung Cancer PHASE2 This study evaluated the effectiveness and safety of Camrelizumab combinati...
Show More Location
Sichuan Cancer Hospital & Institute
Learn More & Join Trial
Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer PHASE2 A single arm phase II study of pembrolizumab, carboplatin, paclitaxel, and ...
Show More Location
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Learn More & Join Trial
Do Markers of Systemic Inflammatory Response and Tumor Metabolism Indicate Radioresistance in Head and Neck Cancer? N/A The aim of the study is to prospectively evaluate whether markers of a pati...
Show More Location
Department of Otorhinolaryngology - Head and Neck Surgery, Cantonal Hospital Lucerne
Learn More & Join Trial
High-dose Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal Cancer NA To assess the efficacy and feasibility of high-dose intensity-modulated rad...
Show More Location
Shanghai Genernal Hospital
Learn More & Join Trial
Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer PHASE1 This is a 2 part Phase I/II clinical trial evaluating the safety, tolerabil...
Show More Location
University of Wisconsin Carbone Cancer Center
Learn More & Join Trial